Uveitis in children

International Ophthalmology Clinics

Volumn 45, Issue 2, 2005, Pages 135-156

  Zierhut, Manfred ^a   Michels, Hartmut ^c   Stübiger, Nicole ^a   Besch, Dorothea ^a   Deuter, Christoph ^a   Heiligenhaus, Arnd ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c Rheumatic Children's Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR; STEROID; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

AMBLYOPIA; ANAPHYLAXIS; ARTHRITIS; CATARACT; CHILD; CINCA SYNDROME; CONTACT LENS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENTHESITIS; EYE SYNECHIA; GLAUCOMA; HUMAN; INFLAMMATORY DISEASE; INTERSTITIAL NEPHRITIS; INTRAOCULAR HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE XANTHOGRANULOMA; KERATOPATHY; LENSECTOMY; LEUKEMIA; NEOPLASM; NEWBORN DISEASE; OPHTHALMOLOGY; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETINA MACULA EDEMA; RETINOBLASTOMA; REVIEW; SARCOIDOSIS; SCREENING; SIDE EFFECT; SPECTACLES; UVEITIS; VISUAL DEPRIVATION; VISUAL IMPAIRMENT; VITREOUS OPACITY;

ARTHRITIS, JUVENILE RHEUMATOID; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; DERMATITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; NEPHRITIS, INTERSTITIAL; PREVALENCE; SARCOIDOSIS; UVEITIS;

EID: 17644401004     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000155903.87679.c2     Document Type: Review

References (51)

1. Cunningham ET Jr. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251-261.
2. Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. J Ophthalmology. 2003;135:867-878.
3. Okada AA, Foster CS. Posterior uveitis in the pediatric population. Int Ophthalmol Clin. 1992;32:121-152.
4. Tugal-Tutkun I, Havrlikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375-383.
5. Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children: a pediatric rheumatology perspective. Am J Ophthalmol. 2003;135:879-884.
6. Kotaniemi K, Kaipiainen-Seppänen O, Savolainen A, et al. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1999;17:119-122.
7. Brewer EJ, Bass J, Cassidy JT, et al. Criteria for the classification of juvenile rheumatoid arthritis. Bull Rheum Dis. 1973;23:712-719.
8. Wood P. Nomenclature and classification of arthritis in children. In: Munthe E, editor. The Care of Rheumatic Children. Basle: EULAR Publishers; 1978:47-50.
9. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-392.
10. Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology. Philadelphia, PA: W.B. Saunders; 2001:218-321.
11. Michels H, Schuchmann L, Truckenbrodt H, et al. Die rheumatische Iridozyklitis im Kindesalter - Differenzierung nach klinischen und immunologischen Gesichtspunkten. Klin Padiatr. 1982;194:104-108.
12. Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986;29:797-800.
13. Hāfner R, Michels H. Psoriatic arthritis in children. Curr Opin Rheumatol. 1996;8:467-472.
14. American Academy of Pediatrics. Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993;92:295-296.
15. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997;24:2031-2034.
16. Chia A, Lee V, Graham EM, et al. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757-762.
17. Edelsten C, Lee V, Bentley CR, et al. An elevation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51-56.
18. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242-1248.
19. Rothova A. Corticosteroids in uveitis. Ophthalmol Clin North Am. 2002;15:389-394.
20. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double blind, placebo-controlled trial. N Engl J Med. 1992;326:1043-1049.
21. Samson CM, Waheed N, Baltatzis S, et al. Methotrexate therapy for chronic non-infectious uveitis. Analysis of a case series of 160 patients. Ophthalmology. 2001;108:1134-1139.
22. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr. 1998;133:266-268.
23. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin. 1992;32:241-252.
24. Kilmartin DJ, Forrester JV, Dick AD. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol. 1998;82:737-742.
25. Kotaniemi K. Late onset uveitis in juvenile-type chronic polyarthritis controlled with prednisolone, cyclosporin A and methotrexate. Clin Exp Rheumatol. 1998;16:469-471.
26. Miserocchi E, Balzatzis S, Ekong A, et al. Efficacy and safety of chlorambucil in intractable noninfectious uveitis. Ophthalmology. 2002;109:137-142.
27. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum. 2001;44:1411-1415.
28. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252-257.
29. Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236-244.
30. Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29:2446-2453.
31. Edelsten C, Reddy A, Stanford MR, et al. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676-680.
32. Mandeville JTH, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46:195-208.
33. Laatikainen LT, Immonen IJR. Acute posterior multifocal placoid pigment epitheliopathy in connection with acute nephritis. Retina. 1988;8:122.
34. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44:653-657.
35. Gion N, Stavron P, Foster CS. Immunomodulatory therapy for chronic tubulointerstitial nephtritis-associated uveitis. Am J Ophthalmol. 2000;107:764.
36. Dollfus H, Häfner R, Hofmann HM, et al. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol. 2000;118:1386-1392.
37. Hull KM, Shoham N, Chae JJ, et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol. 2003;15:61-69.
38. Neven B, Callebaut I, Prieur AM, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2004;103:2809-2815.
39. Prieur AM, Griscelli C, Lampert F, et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol. 1987;66(Suppl):57-68.
40. Hawkins PN, Lachmann HJ, Aganna E, et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50:607-612.
41. Federico G, Rigante D, Pugliese AL, et al. Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol. 2003;32:312-314.
42. West SG, Kotzin BL. Sarcoidosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. Edinburgh: Mosby; 2003:1735-1745.
43. Lindsley CB. Granulomatous vasculitis, giant cell arteritis, and sarcoidosis. In: Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology. Philadelphia, PA: W.B. Saunders; 2001:604-627.
44. Häfner R, Vogel P. Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol. 1993;11:685-691.
45. Rosenthal AR. Ocular manifestations of leukemia: a review. Ophthalmology. 1983;90:899-905.
46. Cho AS, Holland GN, Glasgow BJ, et al. Ocular involvement in patients with postransplant lymphoproliferative disorder. Arch Ophthalmol 2001;119:183-189.
47. Rohrbach JM, Kröber SM, Teufel T, et al. EBV-induced polymorphic lymphoprolifer-ative disorder of the iris after heart transplantation. Graefes Arch Clin Exp Ophthalmol. 2004;242:44-50.
48. Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100:809-817.
49. Lam LA, Lowder CY, Baerveldt G, et al. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis. Am J Ophthalmol. 2003;135:772-778.
50. von Noorden GK, Campos EC. Bonocular Vision and Ocular Motility. Theory and Management of Strabismus. St. Louis, MO: Mosby; 2002.
51. Piantanida A, Vergani D. Successful occlusion therapy in compliant amblyopic elderly children. In: Spiritus M, ed. Transactions of the 25th Meeting of the European Strabismological Association, Jerusalem, September 1999. Lisse: Aeolus Press; 2000:41.